Indian Immunologicals Limited (IIL), a subsidiary of the state-owned National Dairy Development Board based in Hyderabad, India, announced the launch of a live-attenuated needle-free intra-nasal booster vaccine developed against SARS-CoV-2. According to the company, the vaccine has been developed using codon deoptimization technology in collaboration with Griffith University, Australia.The vaccine's...